Lack of prognostic value of EGFR mutations in primary resected non-small cell lung cancer

By Lim Ken-Hong   Huang Ming-Jer   Liu Hung-Chang   Kuo Hsu-Tah   Tzen Chin-Yuan   Hsieh Ruey-Kuen  

Medical Oncology, Vol. 24, Iss. 4, 2007-12 ,pp. : 388-393

Humana Press, Inc

Access to resources Recommend Favorite

Significance of CXCR4, phosphorylated STAT3 and VEGF-A expression in resected non-small cell lung cancer

By Wang Meng   Chen Gong-Yan   Song Hong-Tao   Hong Xuan   Yang Zhao-Yang   Sui Guang-Jie  

Experimental and Therapeutic Medicine, Vol. 2, Iss. 3, 2011-05 ,pp. : 517-522

Spandidos Publications

Access to resources Recommend Favorite

Spinal Infarction Related to the Adjuvant Chemotherapy for Surgically Resected Non-small Cell Lung Cancer: Report of a Case

By Matsutani Noriyuki   Kawamura Masafumi  

Japanese Journal of Clinical Oncology, Vol. 43, Iss. 5, 2013-05 ,pp. : 569-570

Oxford University Press

Access to resources Recommend Favorite

A randomized phase III trial of adjuvant treatment for resected non-small cell lung cancer in Japan

By Ichinose Yukito  

Cancer Chemotherapy and Pharmacology, Vol. 58, Iss. 7, 2006-11 ,pp. : 43-48

Springer Publishing Company

Access to resources Recommend Favorite

A randomized phase III trial of adjuvant treatment for resected non-small cell lung cancer in Japan

By Ichinose Yukito  

Cancer Chemotherapy and Pharmacology, Vol. 58, Iss. 1, 2006-11 ,pp. : 43-48

Springer Publishing Company

Access to resources Recommend Favorite